zinforo
pfizer ireland pharmaceuticals - ceftarolino fosamilis - community-acquired infections; skin diseases, infectious; pneumonia - antibacterials sisteminio naudojimo, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
penicilina g sodica
adeofarma, uab - benzilpenicilinas - milteliai injekciniam ar infuziniam tirpalui - 1000000 tv - benzylpenicillin
piperacillin/tazobactam teva
teva pharma b.v. - piperacilinas/tazobaktamas - milteliai infuziniam tirpalui - 4000 mg/500 mg - piperacillin and beta-lactamase inhibitor
cefotaxime mip
mip pharma gmbh - cefotaksimas - milteliai injekciniam ar infuziniam tirpalui - 1 g; 2 g - cefotaxime
linezolid accord
accord healthcare b.v. - linezolidas - infuzinis tirpalas - 2 mg/ml - linezolid
calrecia
fresenius medical care deutschland gmbh - kalcio chloridas dihidratas - infuzinis tirpalas - 100 mmol/l - calcium chloride
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibacterials sisteminio naudojimo, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių.
piperacillin/tazobactam kalceks
as kalceks - piperacilinas/tazobaktamas - milteliai infuziniam tirpalui - 2000 mg/250 mg - piperacillin and beta-lactamase inhibitor
piperacillin/tazobactam kalceks
as kalceks - piperacilinas/tazobaktamas - milteliai infuziniam tirpalui - 4000 mg/500 mg - piperacillin and beta-lactamase inhibitor
piperacillin/tazobactam qilu
qilu pharma spain s.l. - piperacilinas/tazobaktamas - milteliai infuziniam tirpalui - 4 g/0,5 g - piperacillin and beta-lactamase inhibitor